Cargando…
Getting the Right Evidence After Drug Approval
To generate comparative evidence in a timely fashion for drugs without restricting or delaying access, value-based pricing and reimbursement could be conditioned on a prospective, post-approval evidence generation plan.
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509198/ https://www.ncbi.nlm.nih.gov/pubmed/33013409 http://dx.doi.org/10.3389/fphar.2020.569535 |